Aknamed: Financial Breakdown
Decoding financial health metrics of Aknamed
Total Revenue₹207.7 Cr+-45%Prev. FY
Total Expenses₹404.6 Cr+-32%Prev. FY
Profit After Tax₹-385.2 Cr+-72%Prev. FY
Total Assets₹341.9 Cr+-48%Prev. FY
Net Profit Margin-185.5%-212%Prev. FY
FAQs on Financials of Aknamed
No. In FY24, Aknamed reported a net loss of ₹385.2 Cr+, so it was not profitable.
Aknamed's revenue declined 44.9% year-on-year, from ₹376.6 Cr+ in FY23 to ₹207.7 Cr+ in FY24.
Aknamed's estimated EBITDA for FY24 was ₹-342.8 Cr+, derived from its profit before tax, finance costs, and depreciation & amortisation.
In FY24, Aknamed posted revenue of ₹207.7 Cr+ (down 44.9% YoY) and a net loss of ₹385.2 Cr+. Explore the full financials of Aknamed here...
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links